✦ LIBER ✦

165. Development and validation of the 6-min walk test as a clinical endpoint in Duchenne and Becker muscular dystrophy

✍ Scribed by C.M. McDonald; E. Henricson; J.J. Han; T. Abresch; J. Barth; A. Reha; G. Elfring; S. Peltz

Book ID: 116371447
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 37 KB
Volume: 123
Category: Article
ISSN: 1388-2457
DOI: 10.1016/j.clinph.2011.11.246

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

T.P.1.02 The 6 min walk test (6MWT)

T.P.1.02 The 6 min walk test (6MWT) as a clinical trial outcome measure in Duchenne/Becker Muscular Dystrophy (DMD/BMD)

✍ C.M. McDonald; E.K. Henricson; J.J. Han; A.R. Nicorici; R.T. Abresch; L.A. Atkin 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 49 KB

P.2.8 The 6-min walk test and clinical e

P.2.8 The 6-min walk test and clinical endpoints in Duchenne MD: Reliability, validity, and clinically-important differences

✍ McDonald, C.M.; Henricson, E.K.; Abresch, R.T.; Florence, J.M.; Eagle, M.; Gappm 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 48 KB

The 6-minute walk test as a new outcome

The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy

✍ Craig M. McDonald; Erik K. Henricson; Jay J. Han; R. Ted Abresch; Alina Nicorici 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB

## Abstract Walking abnormalities are prominent in Duchenne muscular dystrophy (DMD). We modified the 6‐minute walk test (6MWT) for use as an outcome measure in patients with DMD and evaluated its performance in 21 ambulatory boys with DMD and 34 healthy boys, ages 4 to 12 years. Boys with DMD were